These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2533684)

  • 1. Pharmacokinetics of etretinate in psoriatic patients with liver fibrosis.
    Larsen FG; Nielsen-Kudsk F; Jakobsen P; Kragballe K
    Pharmacol Toxicol; 1989 Nov; 65(5):393-7. PubMed ID: 2533684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients.
    Larsen FG; Jakobsen P; Larsen CG; Kragballe K; Nielsen-Kudsk F
    Pharmacol Toxicol; 1988 Mar; 62(3):159-65. PubMed ID: 2967472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol.
    Larsen FG; Jakobsen P; Knudsen J; Weismann K; Kragballe K; Nielsen-Kudsk F
    J Invest Dermatol; 1993 May; 100(5):623-7. PubMed ID: 8491984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose pharmacokinetics of etretin and etretinate in psoriatic patients.
    Larsen FG; Jakobsen P; Larsen CG; Nørgaard A; Kragballe K; Nielsen-Kudsk F
    Pharmacol Toxicol; 1987 Aug; 61(2):85-8. PubMed ID: 2959917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of etretinate with methotrexate pharmacokinetics in psoriatic patients.
    Larsen FG; Nielsen-Kudsk F; Jakobsen P; Schrøder H; Kragballe K
    J Clin Pharmacol; 1990 Sep; 30(9):802-7. PubMed ID: 2277127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and suction blister fluid levels of etretinate and its main metabolite during treatment of psoriasis.
    Lauharanta J; Paravicini U
    Arch Dermatol Res; 1982; 272(1-2):147-9. PubMed ID: 6219628
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacokinetics of acitretin and its 13-cis-metabolite in psoriatic patients.
    Larsen FG; Jakobsen P; Eriksen H; Grønhøj J; Kragballe K; Nielsen-Kudsk F
    J Clin Pharmacol; 1991 May; 31(5):477-83. PubMed ID: 1828811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study.
    Gollnick H; Bauer R; Brindley C; Orfanos CE; Plewig G; Wokalek H; Hoting E
    J Am Acad Dermatol; 1988 Sep; 19(3):458-68. PubMed ID: 2971692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.
    Bjerke JR; Geiger JM
    Acta Derm Venereol Suppl (Stockh); 1989; 146():206-7. PubMed ID: 2532847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of route of administration on the pharmacokinetics of etretinate in the dog.
    Bornemann LD; Cotler S; Khoo KC; Carbone JJ; Colburn WA
    Biopharm Drug Dispos; 1988; 9(1):119-26. PubMed ID: 2963666
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacokinetics of etretinate, acitretin and 13-cis-acitretin: new results and advantages of blood level oriented clinical use].
    Gollnick H; Rinck G; Bitterling T; Orfanos CE
    Z Hautkr; 1990 Jan; 65(1):40-50. PubMed ID: 2139274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etretinate pharmacokinetics in chronic renal failure. A preliminary study in psoriasis patients.
    Vahlquist A
    Dermatologica; 1987; 175(5):224-8. PubMed ID: 2960573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. II. Single and multiple oral dosing studies.
    Brouwer KR; McNamara PJ
    Drug Metab Dispos; 1989; 17(6):652-5. PubMed ID: 2575502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic pharmacokinetics of acitretin, etretinate, isotretinoin, and acetylenic retinoids in guinea pigs and obese rats.
    Chien DS; Sandri RB; Tang-Liu DS
    Drug Metab Dispos; 1992; 20(2):211-7. PubMed ID: 1352212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. I. Intravenous studies.
    Brouwer KR; McNamara PJ
    Drug Metab Dispos; 1989; 17(6):646-51. PubMed ID: 2575501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic profile of two aromatic retinoids (etretinate and acitretin) in the obese Zucker rat.
    McNamara PJ; Blouin RA
    J Pharm Sci; 1990 Apr; 79(4):301-4. PubMed ID: 2141075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
    Meffert H; Sönnichsen N
    Acta Derm Venereol Suppl (Stockh); 1989; 146():176-7. PubMed ID: 2532846
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacokinetics of etretinate and its metabolites in the dog.
    Thongnopnua P; Massarella JW; Zimmerman CL
    Drug Metab Dispos; 1989; 17(5):473-80. PubMed ID: 2573489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: a possible model for the extended elimination phase in human therapy.
    Löfberg B; Reiners J; Spielmann H; Nau H
    Dev Pharmacol Ther; 1990; 15(1):45-51. PubMed ID: 2147001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etretinate kinetics during chronic dosing in severe psoriasis.
    Massarella J; Vane F; Buggé C; Rodriguez L; Cunningham WJ; Franz T; Colburn W
    Clin Pharmacol Ther; 1985 Apr; 37(4):439-46. PubMed ID: 3979005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.